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Abstract
With poor health and widespread drug problems in the U.S. prison population,
post-prison drug use provides an important measure of both public health and
social integration following incarceration. We study the correlates of drug use
with data from the Boston Reentry Study (BRS), a survey of men and women
interviewed four times over the year after prison release. The BRS data allow
an analysis of legal and illegal drug use, and the correlation between them.
We find that illegal drug use is associated with histories of drug problems and
childhood trauma. Use of medications is associated with poor physical health
and a history of mental illness. Legal and illegal drug use are not strongly
correlated. Results suggest that in a Medicaid expansion state where health
coverage is widely provided to people leaving prison, formerly-incarcerated men
and women use medications, not illegal drugs, to address their health needs.
Keywords: Massachusetts; incarceration; drug use; Medicaid; childhood
trauma
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Over 600,000 people, largely from poor minority communities, are released
from prison each year (Carson, 2016; Simes, 2016). With histories of poor health
and substance use disorders, those making the transition from incarceration to
community face significant obstacles to successful reentry (Schnittker et al.,
2011). Drug use after prison release is a key indicator of social integration.5
Illegal drug use is a negative indicator, related to criminal involvement, relapse
to addiction, and an elevated risk of mortality (Binswanger et al., 2007; Mowen
and Visher, 2015a). Less studied, but equally important, legal drug use is a
positive indicator, linked to continuity of medical care, adherence to treatment,
and access to community-based providers. In different ways then, illegal and10
legal drug use are informative about risky behaviors, social support, and overall
health and well-being after incarceration.
Social integration depends on pre-prison risk factors and the post-prison
reentry process. Among pre-prison risk factors, mental illness, a history of drug
problems, and childhood trauma are highly prevalent in prison populations, and15
are markers of frailty that make drug use more likely (Dube et al., 2003; Min
et al., 2007). After prison release, drug use is also likely to depend on health
status and the social environment of reentry. For example, parole supervision
and transitional housing programs impose drug testing that may deter illegal
drug use. Returning to a supportive family has also been found to reduce illegal20
drug use after incarceration (Mowen and Visher, 2015a). Besides these aspects
of the reentry environment, poor health after prison may necessitate the use of
medications where health care is accessible.
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Correlations between different kinds of drug use are also informative about
social integration after incarceration. For a population in poor health with a his-25
tory of criminal involvement, illegal drugs may be used to alleviate symptoms
of mental illness or chronic pain that might otherwise be managed by medi-
cations (Khantzian, 1985; Pickard, 2012). This hypothesis of self-medication
suggests that legal and illegal drug use should be studied together, and the two
may be correlated. Self-medication with illegal drugs stymies social integration.30
Health needs are addressed through illicit drug markets and without the con-
sistent support of a health care provider. Still, in the small literature on drug
use after incarceration, no study that we know examines legal and illegal drug
use together (e.g. Binswanger et al., 2012; Seal et al., 2007; Mowen and Visher,
2015a). In short, studying the correlates of legal and illegal drug use, and the35
association between them, are central to understanding social integration after
incarceration.
The current study of drug use after incarceration analyzes data from the
Boston Reentry Study (BRS), a unique longitudinal survey that follows a sample
of men and women over the first year after release from Massachusetts prisons.40
Based on four post-release interviews over the first year after incarceration, the
data offer granular detail on patterns of illegal and legal drug use in a state that
pioneered the expansion of Medicaid for the formerly-incarcerated and other
low-income people.
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Drug Use After Prison45
Drug use after prison is a key focus for reentry programming efforts, commu-
nity corrections supervision, and an important measure of public health. Despite
the obvious policy and health significance, most research has focused on drug
use by arrestees or prisoners, and not the formerly-incarcerated (e.g. Cooper
et al., 2012; Fazel et al., 2006). The review by Larney and her colleagues iden-50
tified eight studies published between 2004 and 2014 that analyzed illegal drug
use, hazardous drinking, and tobacco use over a one week to 12 month follow-
up period following release from incarceration (Larney et al., 2018). Incidence
estimates are generally not comparable across studies, but some results suggest
that drug use after incarceration is at least twice as common as in the general55
population. While research suggests the high rate of drug use, studies often
rely on convenience samples and suffer from high rates of attrition, typically
between 25 and 50 percent over 3 to 12 months of follow-up. If drug use itself
contributes to study dropout, the incidence of drug use will be underestimated
and the association between drug use and socio-economic disadvantage is also60
likely to be attenuated (see Western et al., 2016).
Researchers have focused on the use of illegal drugs and not prescribed med-
ications. Incarcerated men and women, however, carry heavy burdens of infec-
tious disease, chronic conditions, and mental illness (Travis et al., 2014). Prison
authorities are constitutionally obliged to provide health care. Perhaps as a65
result, treatment and health have been found to be better in prison than imme-
diately after release (Mallik-Kane and Visher, 2008; Wildeman and Wang, 2017).
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In light of their poor health, the use of medications by formerly-incarcerated
people is an important positive health behavior that should form part of an
assessment of post-prison drug use.70
The Boston Reentry Study collected data on legal and illegal drug use in a
representative sample of Massachusetts state prisoners released to the Boston
area. Unusually for reentry research, the BRS sustained a response rate of 94
percent percent over the yearlong follow-up period, with a retention rate of 91
percent by the final exit interview. The survey asked respondents to report on75
whether they ever used a variety of drugs since the last survey interview. Unlike
most earlier research, the BRS data distinguished hard drugs (including cocaine
and heroin) from cannabis. A separate module asked about prescription drug
use, recording medications for pain, mental health disorders, and other medical
conditions.80
Figure 1 shows the level of illegal and legal drug use in the BRS sample at four
follow-up interviews at one week, two months, six months, and 12 months after
prison release. These four measures provide the dependent variables for this
study. The proportion of the sample reporting any drug use is shown separately
for respondents who have no history of drug or alcohol problems, and those that85
do. A history of drug problems is indicated by a positive response to the survey
question: Has drug or alcohol addiction ever been an issue for you? A history
of drug problems was reported by about half of all respondents. The use of
hard drugs is almost entirely confined to those with a history of drug or alcohol
problems. The rate of cannabis use is higher than the rate of hard drug use, and90
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Figure 1. Proportion of respondents in the year after prison release reporting use of:
(1) hard drugs, (2) cannabis, (3) medications for mental health, (4) medications for
pain, Boston Reentry Study.
does not vary with drug and alcohol history. These rates of illegal drug use are
significantly higher than those reported in general population surveys. Finally,
the use of mental health medication increases significantly over the year after
incarcation, but the use of pain medication changes little.
Pre-Prison Risks and Post-Prison Health and Social Environment95
The correlates of drug use after incarceration include pre-existing risk fac-
tors and post-release measures of health and social environment. We explore
the relationship of post-prison drug use to three pre-prison risk factors: a his-
tory of drug and alcohol problems, exposure to trauma in childhood, and poor
mental health. Incarcerated men and women report drug use problems at sig-100
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nificantly higher rates than the general population. A review of estimates finds
that 25 percent of U.S. prisoners report histories of drug dependence compared
to estimates of around 3 percent for the general population (Fazel et al., 2006;
Peugh, 2005; Merikangas and McClair, 2012). Drug dependence and substance
use disorder are chronic conditions often marked by cycles of relapse and recov-105
ery (McLellan et al., 2000). We thus expect to observe high rates of illegal drug
use among those with a history of drug and alcohol problems at baseline.
A history of drug and alcohol problems is closely related to exposure to
trauma in childhood (Peters et al., 2015; Cuomo et al., 2008). People who have
been incarcerated have often lived in chaotic and dangerous home environments110
as children (Messina et al., 2007; Western, 2015). Qualitative studies indicate
extensive histories of family violence, witnessing violence, and family disruption
in the lives of formerly-incarcerated men and women (Black, 2010; Sered and
Norton-Hawk, 2014; Western, 2018). Childhood trauma has been linked to
adult drug use as a means to address the adult psychological effects of trauma,115
or other maladaptive coping behaviors (Widom et al., 1999). We thus expect
that childhood histories of trauma will be closely associated with drug use after
prison release.
Poor mental health has also been widely associated with drug use in ado-
lescence and adulthood. Childhood emotional distress, adult depression, and120
social alienation have frequently been reported for heavy drug users (Swendsen
and Merikangas, 2000). The Urban Institute’s Returning Home study found 1
in 10 men and 1 in 4 women reported a dual diagnosis of mental health and
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substance abuse conditions (Mallik-Kane and Visher, 2008). Poor health and
mental health diagnoses may be risk factors for drug use because of underlying125
common causes, prescribed medical treatment, or in the case of illegal drugs,
self-medication (Crutchfield and Gove, 1984; Khantzian, 1985; Pickard, 2012).
After prison release, poor health is a likely proximate cause of legal and illegal
drug use. A large research literature has documented the poor and declining
health of people released from incarceration. High rates of infectious disease130
and stress-related illness have been reported in survey data in the years after
incarceration (Massoglia, 2008). Other survey estimates indicate relatively few
health impairments during incarceration, but health deteriorates after release
(Schnittker and John, 2007). Poor health may be related to legal drug use where
patients are prescribed medications for diagnosed conditions, or illegal drug use135
where they are self-medicating conditions such as chronic pain or ongoing mental
illness.
Health status itself likely depends on a broader social context that also
influences the likelihood of drug use. Through social connection, parental mon-
itoring, and material or emotional support, families may be a protective factor140
against substance use and relapse during the reentry process. Family support
has been linked to lower rates of recidivism and reduced drug use in the first
months after incarceration (Western et al., 2015; Mowen and Visher, 2015b;
Visher and Courtney, 2006). Besides the informal monitoring by family mem-
bers, illegal drug use among those released from prison is often directly scruti-145
nized by probation and parole officers who conduct regular drug tests as a con-
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dition of community supervision. Residential drug treatment programs, called
sober houses in Massachusetts, also conduct regular drug tests of residents,
thereby reducing the use of illegal drugs (O’Connell et al., 2016).
Ordinarily, the drugs studied here—hard drugs, cannabis, and medications150
for pain and mental health disorders—would be treated as four independent out-
comes. However, the outcomes may be correlated because of self-medication.
With self-medication, illegal drugs are used in the absence of medical care to
cope with chronic conditions, environmental stressors, and mental illness. If
illegal drugs and medications were substitutes, we would expect a negative cor-155
relation. If illegal drugs and medications were used alternately we would expect
a positive correlation. Self-medication with illegal drugs is of particular concern
for disadvantaged and vulnerable groups (Khantzian, 1985). Several observa-
tional studies of homeless youth, for example, find substance use was reported
as an adaptive response to mental illness, pain, and survival on the streets (Klee160
and Reid, 1998; Christiani et al., 2008; Holt and Treloar, 2008). In the analy-
sis below we study the possibility of self-medication by estimating correlations
among random effects across equations for legal and illegal drug use.
The hypothesis of self-medication has a variety of empirical implications—
including correlations between legal and illegal drug use. However, self-medication165
may also depend on the policy environment governing access to health care. Na-
tionwide, estimates indicate that only 20 percent of those released from prison
have health insurance (Mallik-Kane and Visher, 2008). Massachusetts, however,
expanded Medicaid eligibility for low income single men under Governor Mitt
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Romney in 2005. Several years later, the Department of Correction (DOC) with170
the University of Massachusetts (UMass) began a program of enrollment in the
state Medicaid plan, called MassHealth. As a result, 96 percent were covered
by MassHealth at the one-week interview. Of those covered by MassHealth,
85 percent received help from the UMass-DOC program to enroll while incar-
cerated, and 98 percent thought MassHealth coverage would be helpful upon175
release. One year after release, health coverage remained consistently above 90
percent among BRS respondents. We might expect that high rates of insurance
coverage would attenuate the correlation between legal and illegal drug use, but
we leave this an empirical question for the data analysis below.
Data and Methods180
The BRS is a panel survey, fielded from 2012 to 2014, that interviewed 122
men and women released from state prison in Massachusetts (Western et al.,
2016). All prison releasees who provided a Boston-area address for reentry were
eligible to participate, and could could volunteer for the study by responding to
an information sheet provided by prison staff. The sample includes 26 percent of185
all Boston-area prison releases in the recruitment period, and is representative
of the population of prison-releasees in demographic characteristics, criminal
history, and recidivism. The longitudinal design began with a baseline interview
a week before prison release, and four face-to-face follow-up interviews were
conducted by a team of staff researchers and graduate students over the following190
year. After accounting for survey attrition and other missing data, sample size
for the current analysis includes 111 respondents who contribute 402 follow-up
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interviews to the data set.
The current analysis examines data on legal and illegal drug use. Illegal
drug use was measured with a self-administered module that the respondent195
completed with pen and paper and returned to the interviewer in a sealed en-
velope. The sealed and self-administered drug module was intended to improve
the respondent’s sense of confidentiality of the responses. Data on legal drug use
was obtained from a health module that asked respondents about their medical
conditions, treatment, and medications. Medications were divided into treat-200
ments for pain, mostly used to manage chronic pain and arthritis, and mental
health medications that were prescribed for depression, anxiety, and bipolar
disorder.
The analysis examines four dependent variables: the use of (1) hard drugs
(cocaine, crack, methamphetamine, heroin and ecstasy), (2) cannabis, (3) med-205
ications for mental health disorders, and (4) medications for pain. We group
together hard drugs because they pose serious risks to health and safety in their
purchase and use. We also analyze pain and mental health medications sep-
arately because each outcome may depend differently on physical and mental
health. For each of the four dependent variables, respondents reported whether210
they had used drugs since the last survey interview. These data are more de-
tailed than in earlier studies of drug use after incarceration because follow-up
interviews are conducted at high frequency (four interviews in a year), and the
data are more detailed (distinguishing hard drugs and cannabis, and different
types of medications).215
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Predictors include pre-prison risk factors, post-prison measures of health and
social environment, and control variables. Descriptive statistics are reported in
Table 1. Pre-prison risk factors are measured by self-reported histories of drug
and alcohol problems, childhood trauma, and mental illness reported at baseline.
Around half the sample reported drug and alcohol problems and mental illness.220
Childhood trauma is measured by summing six binary indicators of traumatic
experiences, and then standardizing the scale to have a mean of 0 and standard
deviation of 1.0. Indicators comprising the scale show the extensive prevalence
of trauma. For example, 56 percent of respondents grew up with someone
with drug or alcohol problems, nearly half were victims of parental violence,225
and 42 percent witnessed a violent death in childhood. Post-prison health and
social environment are measured by self-rated health scales after prison release,
probation or parole status, residence in a sober house, and a measure of family
support. Control variables include indicators for age, race, and sex, participation
in prison drug programs, the length of stay in prison, and pre-incarceration230
medical care and drug treatment. The control variables aim to account for the
experiences of respondents during and prior to incarceration.
We model the associations between drug use and covariates with logistic re-
gressions that also include random effects for each respondent. Random effects
adjust standard errors for clustering due to the panel structure of the data.
For respondent i in interview wave t, we write the four binary outcomes as Hit
for hard drug use, Cit for cannabis use, Pit for pain medications, and Mit for
mental health medications. Collecting time-invariant covariates that measure
12
Table 1. Description and means of independent variables used in regression analysis
of drug use after incarceration. (N = 111 respondents.)
Variable Name Description Mean (95% CI)
Pre-Prison Risk Factors
Drug and alcohol history Dummy variable measured at baseline for history of
drug or alcohol problems.
.52 (.45, .63)
Childhood trauma Standardized scale (mean=0, s.d.=1) measuring child-
hood history of domestic violence, family drug use,
respondent hit by parent, living with family mem-
ber who is depressed/suicidal, sexually abused, or wit-
nessed death.
.00 (-.19, .19)
Mental illness Dummy variable for history of mental illness reported
at baseline.
.44 (.35, .54)
Post-Prison Health and Social Environment
Self-rated health Time-varying 4-point scale recording whether health
is poor, fair, good, or excellent.
2.02 (1.95, 2.09)
Probation/parole Dummy variable recording probation or parole super-
vision.
.62 (.52, 70)
Sober house Time-varying dummy variable for residence in sober
house or other transitional housing program.
.26 (.22, .31)
Family support Time-varying dummy variable for staying with or re-
ceiving money from a family member.
.60 (.55, .65)
Control Variables
Saw doctor pre-prison Dummy variable indicating saw doctor at least
monthly before incarceration.
.59 (.50, .68)
Drug treatment pre-prison Dummy variable indicating attended drug treatment
before incarceration.
.24 (.16, 31)
Prison drug program Dummy variable for participation in prison drug pro-
gram.
.16 (.10, 24)
Time served Length of stay in months for most recent incarceration. 33.44 (27.20, 37.64)
Age Age of respondent in years at the baseline survey. 36.48 (34.61, 38.34)
Female Dummy variable for female respondents. .14 (.07, .19)
White Dummy variable for non-Hispanic white respondents. .30 (.22, 39)
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pre-prison risk factors in the vector x1i and time-varying covariates that mea-
sure well-being and the reentry environment, x2it, logistic regressions for the
probability of drug type d = H,C, P, and M , are written:
logit(pdit) = x
′
1iβd1 + x
′
2itβd2 + θdt + αdi,
where θdt are time fixed effects for each interview wave, and αdi are random
effects for each respondent. The random effects are assumed to follow a normal
distribution with covariance matrix,235
Σ =
 σ
2
H
...
. . .
σHM · · · σ2M

Positive correlations among the random effects for legal and illegal drugs
provide evidence of self-medication. The correlations can be calculated from
the elements of the covariance matrix, rxy = σxy/(σxσy). If illegal drugs are
being used to manage mental illness or chronic health conditions, which might
also be intermittently treated with mental health or pain medications, we would240
expect hard drug and cannabis usage to be correlated with medication use.
For each of the dependent variables we fit two models. The first includes just
the predictors of key interest, time fixed effects, and demographic characteristics
including controls for age, race, and sex of the respondent. The second model
adds controls for experiences with treatment and medical care prior to and245
during incarceration.
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Results
The regression results, reported in Table 2, indicate that the use of heroin,
cocaine, and other hard drugs are closely related to the risks associated with
histories of drug problems and childhood trauma. The odds of hard drug use250
were over six times higher (exp[1.883] = 6.6) for respondents with a history of
drug and alcohol problems compared to those with no such history. A standard
deviation increase on the childhood trauma scale is associated with a doubling
of the odds of hard drug use after incarceration (exp[.832] = 2.3). While risk
factors are positively related to high levels of hard drug use, family support255
may be protective. The odds of hard drug use for respondents who received
housing or financial help from family were less than 20 percent of the odds for
those with no family support. Although probation and parole and sober house
treatment programs tested regularly for drug use, these conditions of reentry
were unrelated to the use of hard drugs.260
Results for cannabis show a different pattern. While a history of drug and
alcohol problems is unrelated to cannabis use, respondents who have suffered
childhood trauma frequently report using cannabis. A standard deviation in-
crease in the childhood trauma scale is associated with more than a fourfold
increase in the odds of cannabis use (exp[1.542] = 4.7). Unlike the result for265
hard drugs, family support is not significantly associated with cannabis. Results
for post-prison factors also differ for cannabis use. Respondents under parole
and probation supervision use cannabis at relatively low rates. If regular drug
testing is the mechanism by which parole and probation are influencing drug
15
Table 2. Logistic regression results (log odds) for analysis of illegal drug and medica-
tion use in the first year after prison release. (Absolute z statistics in parentheses.)
Pain Mental Health
Hard Drugs Cannabis Medication Medication
Pre-Prison Risk Factors
Drug and alcohol history 2.560** 1.883* -.308 -.860 .729 1.288 2.058** 1.664*
(2.65) (2.01) (.30) (.78) (.80) (1.37) (2.74) (2.06)
Childhood trauma .710 .832* 1.392** 1.542** -.517 -.653 -.169 -.245
(1.85) (2.02) (2.69) (2.85) (1.30) (1.62) (.58) (.80)
Mental illness -.903 -1.112 -1.064 -1.188 .858 .736 3.112** 3.042**
(1.16) (1.38) (1.04) (1.18) (1.06) (.98) (4.54) (4.48)
Post-Prison Health and Social Environment
Self-rated health -.541 -.388 .473 .607 -.977* -1.074** -.483 -.486
(1.53) (1.09) (1.22) (1.56) (2.49) (2.78) (1.57) (1.56)
Family support -1.749* -1.768* 1.029 1.329 1.799* 1.611 .763 .692
(2.50) (2.41) (1.48) (1.87) (2.10) (1.93) (1.58) (1.42)
Probation/parole -.491 -.649 -3.349** -3.425** .184 .152 -.236 -.302
(.71) (.98) (3.17) (3.26) (.24) (.21) (.43) (.54)
Sober house/shelter -.171 .163 -1.374 -1.103 .670 .434 .903 .898
(.27) (.25) (1.45) (1.18) (.93) (.61) (1.71) (1.66)
Constant -4.031* -3.703* -2.927 -1.967 -5.579** -6.054** -5.649** -5.531**
(2.43) (2.30) (1.68) (1.02) (2.70) (2.76) (4.14) (3.90)
Controls: No Yes No Yes No Yes No Yes
∗p < .05 ∗∗p < .01
Note: All models control for age, sex, race, and fixed effects for interview waves. Con-
trol variables include participation in a prison drug program, pre-incarceration drug
treatment, pre-incarceration medical care, and duration of incarceration. Correlated
random effects are fit for each respondent. Respondents N = 111; respondent-waves
N = 402.
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Table 3. Correlation matrix of random effects from logistic models of hard drug use,
cannabis use, and medication use for models with and without control variables.
Hard Pain
Drugs Cannabis Medication
No Controls
Cannabis .668
Pain Medication −.508 .045
Mental Health Medication .261 .363 .180
Including Controls
Cannabis .659
Pain Medication −.461 .275
Mental Health Medication .219 .385 .230
use, we only find evidence for an effect on cannabis and not hard drugs.270
Finally, the results for the use of medications are strikingly different from the
results for illegal drugs. The use of pain medications after release from prison
is closely related to markers of poor physical health. Every additional point
on the four-point self-rated health scale is associated with a reduction in the
odds of medication use by one-third. Beyond health indicators, family support275
was positively associated with the use of pain medications, in contrast to the
results for hard drug use. A history of drug and alcohol problems and childhood
trauma were unassociated with the use of pain medications.
The odds of medications use for mental health disorders among respondents
reporting a history of mental illness are more than 20 times higher than for280
those with no mental illness (exp[3.042] = 20.9). Drug and alcohol history is
also associated with the use of mental health medications, and in this case, may
be reflecting the poor mental health of heavy drug users. Unsurprisingly, parole
and probation supervision and sober house living were unassociated with either
pain or mental health medication use.285
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The logistic regression models for hard drugs, cannabis, and pain and men-
tal health medications include random components that are correlated across
equations. If respondents were alternating or substituting between legal and
illegal drugs, the random effects for medications would be strongly correlated
with, say, the random effects for hard drugs. Instead, Table 3 shows that, across290
models, cannabis and hard drug use are highly correlated, but medication use is
not strongly correlated with illegal drug use, except for a moderate (r ≈ −.5),
negative relationship between hard drug use and pain medications. This offers
some evidence of the substitution of medications with hard drugs. Still, the
correlation is small compared to that for hard drugs and cannabis, and other295
correlations between illegal drugs and medications have the opposite sign.
The weak correlation between legal and illegal drug use provides evidence
against self-medication where illegal drugs are used alternately with legal. Con-
sistent with the expectation that MassHealth coverage attenuates the correlation
between legal and illegal drug use, the results suggest that respondents in poor300
health were able to get the medications they needed and did not substitute with
illegal drugs.
Discussion
Using fine-grained longitudinal data with a high rate of study retention,
we found evidence of a high and increasing rate of drug use through the first305
year after prison release. One in five reentry study respondents used cocaine,
heroin, or other hard drugs in the year after incarceration release. About half
the sample used cannabis and a similar proportion used medications for health
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conditions.
The findings point to three main conclusions. First, illegal drug use is related310
to childhood trauma. While the links between drug use and childhood trauma
have been reported in other research, the consequences of trauma for formerly-
incarcerated people are less often studied. Reentry policy is often focused on
behavioral change or meeting the immediate needs of housing and employment
after incarceration. The reentry study respondents report high rates of child-315
hood trauma, and this is closely associated with post-prison health outcomes.
Trauma emerges in this analysis as an important target for policy intervention.
Second, the results suggest that regular drug testing that forms part of the
conditions of parole and probation supervision may deter only cannabis use, but
not hard drug use. Respondents on community supervision used cannabis at low320
rates, but hard drug use was unrelated to supervision status. We interpret the
lower incidence of cannabis use for parolees and probationers to stem largely
from the longer detection window of cannabis in urine testing than for other
drugs (Goodwin et al., 2008). Although researchers have evaluated how the
conditions of parole such as unscheduled drug testing affect recidivism (Peter-325
silia and Turner, 1993), fewer studies have examined the effects of community
supervision (versus no supervision) on drug use. The current results suggest
that drug testing during probation and parole may only affect less serious illicit
drug use and does little to curb the use of cocaine and heroin.
Third, the weak correlation between illegal and legal drug use, and between330
health indicators and illegal drugs, tend to disconfirm the claim that illegal drug
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use is often a type of self-medication for health problems. This contrasts with
other research where illegal drug use has been found to substitute for therapeu-
tic remedies and legal drugs, particularly in low-income or reentry populations
(Khantzian, 1985; Klee and Reid, 1998; Christiani et al., 2008; Holt and Treloar,335
2008). We interpret this result in the health policy environment of our Mas-
sachusetts field site, where health insurance is extended to low-income residents
through an expanded Medicaid program. Health insurance coverage immedi-
ately after prison is very high in our sample (96% at the first week after prison
release). In this policy context, the benefits of health care coverage may be340
twofold: improving access to medications, and severing the link between legal
and illegal drug use (see also Rich et al., 2014).
While drug use is closely associated with pre-prison risk factors and post-
prison health and social environments, we emphasize the analysis is only de-
scriptive. Associations of drug use with family support, housing, and health,345
in particular are likely subject to endogeneity bias. Causal inference must go
beyond the observational data presented here to isolate variation in predictors
that does not depend on drug use. Drug use too is measured by self-reports,
and respondents influenced by social desirability bias may under-report drug
use in interviews.350
Drug use is an important marker of social integration. Illegal drug use may
indicate ongoing criminal involvement and presents the possibility of relapse to
substance use disorder. Legal drug use indicates access to medical services and
compliance with treatment. The evidence presented here suggests that histories
20
of drug problems and trauma are hurdles for successful social integration after355
prison. For people leaving prison, who are often poor and in poor health, ex-
panding access to health care may reduce self-medication with illegal drugs and
effectively promote social integration.
21
Appendix
A.1. Logistic regression coefficients for covariates in models illegal drug and med-360
ication use in the first year after prison release. (Absolute z statistics in parentheses.)
Pain Mental Health
Hard Drugs Cannabis Medications Medications
Age 30-44 -.542 -.986 -2.170* -2.199* 1.129 1.434 -.665 -.613
(.61) (1.11) (1.99) (2.02) (1.02) (1.32) (.91) (.84)
Age over 45 -.677 -.486 -4.188** -3.573* 3.295* 3.022* -1.006 -.859
(.68) (.50) (2.64) (2.34) (2.45) (2.37) (1.18) (.99)
Female -.822 -.680 .529 .173 -.025 -.323 -.176 -.460
(.74) (.61) (.41) (.13) (.02) (.28) (.23) (.57)
White 1.597* 1.613* 1.467 1.595 -.009 -.236 1.974** 1.905**
(2.22) (2.34) (1.44) (1.57) (.01) (.30) (3.30) (3.23)
2-month interview 1.813* 1.866* 2.243** 2.276** .015 .038 .642 .650
(2.36) (2.41) (2.87) (2.92) (.03) (.06) (1.24) (1.26)
6-month interview 1.543* 1.652 3.261** 3.343** .253 .197 1.058 1.043
(2.00) (2.13) (3.88) (3.96) (.42) (.33) (1.96) (1.92)
12-month interview 1.721* 1.815* 3.403** 3.528** -.703 -.752 1.876** 1.872**
(2.22) (2.33) (3.91) (4.01) (1.03) (1.12) (3.39) (3.37)
Saw doctor pre-incarceration 1.120 .160 .097 .353
(1.55) (.18) (.13) (.63)
Drug treatment pre-incarceration .727 .648 -.661 .689
(1.02) (.58) (.69) (1.07)
Prison drug program -1.433 -1.553 1.863* .427
(1.44) (1.26) (2.06) (.61)
Length of stay (months) -.022 -.040 * .017 -.007
(1.62) (2.18) (1.61) (.76)
∗p < .05 ∗∗p < .01
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